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a b s t r a c t
Abnormal vascular responsiveness in diabetes has been attributed to a number of changes in contractile
pathways, affected in part by the overproduction of reactive oxygen species (ROS). It has been reported
that NADPH oxidase (NOX) is increased in diabetic (streptozotocin treated; STZ) rat arteries; however the
pharmacological agents used to inhibit NOX activity are known to be unsuitable for in vitro studies and
have a high level of non-selectivity. Here we have used the highly selective NOX inhibitor VAS2870 in
diabetic rat aorta and compared its effects with apocynin, SOD, and allopurinol on phenylephrine and
U46619 induced contraction.
Male Wistar rats were injected intraperitoneally with 65 mg/kg STZ and development of diabetes was
conﬁrmed by testing blood glucose levels. Rats were killed by CO2 asphyxiation, and the thoracic aorta
removed and mounted in an organ bath under a tension of 1 g. Diabetic rat aortas exhibit a greatly
increased response to phenylephrine, which was reduced to a level consistent with control rat aorta by
105 M VAS2870 and 150 U/ml SOD. Incubation with VAS2870 led to an increase in normal rat aorta
contraction, but led to a signiﬁcant reduction in phenylephrine and U46619 induced tone in diabetic rat
aorta, which indicates that ROS in diabetic rats directly contributes to these contractile responses.
Apocynin and allopurinol had no effect on contraction in diabetic or normal rat aorta. This data is the ﬁrst
to show that selective inhibition of NOX reduces diabetic arterial contraction in direct comparison with
inhibition of other known contributors of ROS.
& 2013 The Authors. Published by Elsevier B.V. All rights reserved.
Introduction
The study of reactive oxygen species (ROS) in vascular biology has
been hampered in part by the lack of availability of selective NADPH
oxidase (NOX) inhibitors. Apocynin (1-(4-hydroxy-3-methoxyphe-
nyl)ethanone) is a widely used NOX inhibitor which acts by blocking
NOX assembly and thus needs to be administered orally to have a full
effect. There are a range of non-selective modes of action attributed
to apocynin, including inhibition of RhoA [13] and direct action as an
antioxidant in vascular smooth muscle cells and endothelial cells [7],
which taken together has called into question the use of this inhibitor
[7,13]. New molecules have been developed, such as the cell-
permeable pan NOX inhibitor VAS2870 (7-(2-benzoxazolylthio)-3-
(phenylmethyl)-3H-1,2,3-triazolo[4,5-d]pyrimidine), which abolishes
ROS production without altering baseline ROS [14].
Vascular damage induced by diabetes has been attributed to
the increased production of ROS by NOX [11,17], however the
pharmacological evidence relies on NOX inhibition with apocynin.
In this study, we used inhibitors of ROS production, VAS2870,
apocynin, superoxide dismutase (SOD) and the xanthine oxidase
inhibitor allopurinol on phenylephrine and U46619 induced con-
traction in diabetic and control rats.
Materials and methods
The care and use of all rats in this study was carried out in
accordance with UK Home Ofﬁce regulations, UK Animals (Scien-
tiﬁc Procedures) Act of 1986 under PPL70/6788. Male Wistar rats
(350–450 g) were given a single injection of 65 mg/kg intraper-
itoneally (i.p., DV 10 ml/kg). Streptozotocin (STZ) dissolved in
20 mM citrate buffer (pH 4.5). For 48 h following STZ or control
injection, additional 2% sucrose solution was provided, to avoid the
initial hypoglycaemia that is seen following STZ. Rats were
monitored for a minimum of 2 weeks post-injection, and diabetes
was conﬁrmed by testing a drop of tail vein blood; and rats
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showing an elevated blood glucose of 416 mmol/L were consid-
ered diabetic.
The rats were killed by CO2 asphyxiation and their thoracic
aortas were rapidly removed and dissected in Kreb's buffer (pH
7.4, NaCl 118 mM, KCl 4.7 mM, MgSO4 1.2 mM, KH2PO4 1.2 mM,
CaCl2 2.5 mM, NaHCO3 25.0 mM and glucose 11.0 mM). Aortas
were cut into 2 mm-wide rings after removing the surrounding
connective tissue and fat. Each ring was suspended with silk
thread in a 20 ml organ bath ﬁlled with Kreb's buffer and
maintained at 37 1C. The upper end of the wire was connected to
a force displacement transducer and the lower one connected to
an L-shaped mounting hook. The bath solution was continuously
bubbled with 95% O2 and 5% CO2. An equilibration time of 1 h was
employed during which the aorta rings were tensioned to 1 g.
Arteries were incubated with 105 M 3-benzyl-7-(2-benzoxa-
zolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine (VAS-2870), 105 M
apocynin, 150 U/ml SOD, 105 M allopurinol or vehicle control
for 30 min, followed by increasing concentrations of phenylephr-
ine (108 to 105 M) and U46619 (109 to 3107 M).
Statistical analysis
All data are expressed as mean7standard error of the mean
(SEM). Data was analysed by two-way ANOVA for repeated measure-
ments followed by Bonferroni's post-hoc test, using GraphPad prism
version 4. Differences were considered to be statistically signiﬁcant
when p¼o0.05.
Results
At the time of the experiment, rat biometrics were measured, and
the average weight of rat had signiﬁcantly reduced from a mean of
455 g715 in control rats compared to 383 g711 (n¼12; **po0.01 by
T-test). Blood glucose measurements increased from 6.68 mM70.28
in control rats to 26.61 mM71.35 (n¼12; ***p¼0.001) in diabetic rats.
Phenylephrine induced contraction of aorta from diabetic treated rats
is signiﬁcantly increased compared to vehicle treated control rats
(Fig. 1A), in comparison to U46619 induced contraction which shows
no difference between diabetic and control rat aorta (Fig. 1B). To
ascertain whether the increase in contraction in diabetic rat aorta was
due to ROS production, aorta were incubated with 150 U/ml SOD,
which did not affect contraction in normal rat aorta (Fig. 1C), but
signiﬁcantly reduced phenylephrine induced in diabetic rat aorta
(Fig. 1D). SOD had no effect on U46619 induced contraction from
either type of rat (data not shown).
There were no changes in U46619 or phenylephrine induced
contraction in normal or diabetic rat aorta following incubation
with 105 M apocynin or 105 M allopurinol (data not shown). In
contrast, incubation with 105 M VAS2870 resulted in an increase
in phenylephrine (Fig. 2A) and U46619 (Fig. 2B) induced contrac-
tion in normal rat aorta. In contrast, VAS2870 signiﬁcantly reduced
phenylephrine (Fig. 2C) and U46619 (Fig. 2D) responses in
diabetic aorta.
Conclusion
This study demonstrates that selective inhibition of NOX in the
STZ model of diabetes reduces contraction by phenylephrine to a
level consistent with control aortas. It has been well established in
the literature that diabetes leads to wide spread vascular damage,
attributed largely to the overproduction of ROS in the vasculature
[5], which in turn has been attributed to the up-regulation of NOX
[8]. NOX has become a therapeutic target [4], yet up until recently,
one of the most widely used NOX inhibitors apocynin, which
inhibits the assembly of NOX, has been used in in vitro phar-
macological studies, even though its effects can no longer be
attributed to NOX inhibition. Indeed, apocynin has been shown to
act directly as an antioxidant in vascular tissues [7], and in our
hands apocynin had no effect on aorta contraction to U46619 or
phenylephrine. In order to study the effects of NOX inhibition, we
chose the diabetic STZ rat aorta as a model of vascular damage
induced by overproduction of ROS.
ROS has been shown to contribute to α-adrenergic contractile
responses in endothelium denuded rat tail artery [15]. The α adrener-
gic agonist norepinephrine elicits a signiﬁcantly increased contraction
in diabetic rat aorta andmesenteric arteries [10], which taken together
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Fig. 1. The effects of phenylephrine and U46619 on aorta from diabetic and normal rats. Change in tension (in g) induced by (A) phenylephrine and (B) U46619 in control and
diabetic rat aorta; n¼12. Effects of incubation with 150 U/ml SOD on phenylephrine induced contraction in aorta from (C) normal rat aorta and (D) diabetic rat n¼4. Data are
presented as mean7SEM. Signiﬁcance by two-way ANOVA and Bonferroni's post hoc test is denoted by n¼po0.05, nn¼po0.01, nnn¼po0.001 ns, not signiﬁcant;
compared to respective group within ﬁgure.
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ﬁts well with our data presented here that ROS contributes to
phenylephrine induced contraction of diabetic and not normal rat
aorta. The diabetic rat aorta exhibited a signiﬁcantly increased res-
ponse to phenylephrine compared to control aorta, in keeping with
previous similar ﬁndings [16]. Interestingly SOD signiﬁcantly reduced
phenylephrine responses in diabetic and not control rat aorta,
indicating that the levels of ROS released under control conditions is
minimal, but signiﬁcantly increased in diabetic rats. This supports
recent work showing that deleterious ROS production is extracellular
[6]. However, our ﬁndings contrast with Anozie et al., who showed
that SOD signiﬁcantly decreased phenylephrine contraction from
diabetic rat aorta [1], although this may be explained by the authors
using double the units of SOD than in the study presented here.
There has been some discussion in the literature as to whether
xanthine oxidase contributes to ROS production in the diabetic rat
[12] or is not involved [3]. While a recent study shows that xanthine
oxidase is up regulated in diabetic rat myocardium [9], our data
indicates that xanthine oxidase inhibition with allopurinol has no
effect on U46619 or phenylephrine mediated contraction.
Inhibition of ROS with the inhibitors VAS2870, apocynin,
allopurinol and SOD had no further effect on U46619, indicating
that ROS is not involved in TP receptor contraction in normal or
diabetic rat aorta. In our study, we found that rat aorta responses
to U46619 remains unchanged following the development of
diabetes, which suggests that TP receptor signalling is not affected
by ROS production. This contrasts with previous ﬁndings where it
was shown that U46619 induced contraction of STZ rat aorta is
signiﬁcantly increased [2].
Of central interest to this data is the use of VAS2870 to inhibit
NOX production of ROS in the aorta. Surprisingly, the use of
VAS2870 signiﬁcantly increased the phenylephrine and U46619
mediated responses in control rat aorta. It is well known that the
main dilatory hormone in aorta is nitric oxide, whose biological
activity is critically inﬂuenced by the production of ROS and the
quenching effects of superoxide radicals with nitric oxide results
in the formation of peroxynitrite. In control tissues therefore,
VAS2870 inhibited NOX and the production of ROS inside the cell,
where normally it would react with basally produced nitric oxide;
the reduction in ROS production lead to an increase in contraction
most likely due to the loss of ROS and peroxynitrite production,
and the removal of basally produced nitric oxide.
In contrast, the diabetic rat aorta contraction to phenylephrine
and U46619 was signiﬁcantly reduced by the presence of VAS2870,
to a level consistent to a control rat level, which indicates that ROS
in diabetic rats contributes to these contractile responses directly.
This data is the ﬁrst to show that selective inhibition of NOX
reduces diabetic arterial contraction in direct comparison with
inhibition of other known contributors of ROS, and supports the
use of selective NOX inhibitors in the development of new
therapies for diabetes.
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